115 related articles for article (PubMed ID: 3542534)
1. Pharmacokinetics of primaquine in patients with P. vivax malaria.
Bhatia SC; Saraph YS; Revankar SN; Doshi KJ; Bharucha ED; Desai ND; Vaidya AB; Subrahmanyam D; Gupta KC; Satoskar RS
Eur J Clin Pharmacol; 1986; 31(2):205-10. PubMed ID: 3542534
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics and pharmacodynamics of (+)-primaquine and (-)-primaquine enantiomers in rhesus macaques (Macaca mulatta).
Saunders D; Vanachayangkul P; Imerbsin R; Khemawoot P; Siripokasupkul R; Tekwani BL; Sampath A; Nanayakkara NP; Ohrt C; Lanteri C; Gettyacamin M; Teja-Isavadharm P; Walker L
Antimicrob Agents Chemother; 2014 Dec; 58(12):7283-91. PubMed ID: 25267666
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections.
Li Q; O'Neil M; Xie L; Caridha D; Zeng Q; Zhang J; Pybus B; Hickman M; Melendez V
Malar J; 2014 Apr; 13():141. PubMed ID: 24731238
[TBL] [Abstract][Full Text] [Related]
4. Primaquine treatment and relapse in Plasmodium vivax malaria.
Rishikesh K; Saravu K
Pathog Glob Health; 2016; 110(1):1-8. PubMed ID: 27077309
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of primaquine in man: identification of the carboxylic acid derivative as a major plasma metabolite.
Mihaly GW; Ward SA; Edwards G; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1984 Apr; 17(4):441-6. PubMed ID: 6721990
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective pharmacokinetics of primaquine in healthy human volunteers.
Tekwani BL; Avula B; Sahu R; Chaurasiya ND; Khan SI; Jain S; Fasinu PS; Herath HM; Stanford D; Nanayakkara NP; McChesney JD; Yates TW; ElSohly MA; Khan IA; Walker LA
Drug Metab Dispos; 2015 Apr; 43(4):571-7. PubMed ID: 25637634
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia.
Yeshiwondim AK; Tekle AH; Dengela DO; Yohannes AM; Teklehaimanot A
Acta Trop; 2010 Feb; 113(2):105-13. PubMed ID: 19835832
[TBL] [Abstract][Full Text] [Related]
8. Increased bioavailability of primaquine using poly(ethylene oxide) matrix extended-release tablets administered to beagle dogs.
Bertol CD; Oliveira PR; Kuminek G; Rauber GS; Stulzer HK; Silva MA
Ann Trop Med Parasitol; 2011 Oct; 105(7):475-84. PubMed ID: 22185941
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of primaquine and carboxyprimaquine in Korean patients with vivax malaria.
Kim YR; Kuh HJ; Kim MY; Kim YS; Chung WC; Kim SI; Kang MW
Arch Pharm Res; 2004 May; 27(5):576-80. PubMed ID: 15202566
[TBL] [Abstract][Full Text] [Related]
10. Galactose-Anchored Gelatin Nanoparticles for Primaquine Delivery and Improved Pharmacokinetics: A Biodegradable and Safe Approach for Effective Antiplasmodial Activity against P. falciparum 3D7 and in Vivo Hepatocyte Targeting.
Kumar H; Gothwal A; Khan I; Nakhate KT; Alexander A; Ajazuddin ; Singh V; Gupta U
Mol Pharm; 2017 Oct; 14(10):3356-3369. PubMed ID: 28836792
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of combined chloroquine and primaquine treatment in 14 days versus intermittent single dose regimen, in an open, non-randomized, clinical trial, to eliminate Plasmodium vivax in southern Mexico.
Gonzalez-Ceron L; Rodriguez MH; Sandoval MA; Santillan F; Galindo-Virgen S; Betanzos AF; Rosales AF; Palomeque OL
Malar J; 2015 Oct; 14():426. PubMed ID: 26518132
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Assessment of Chloroquine-Primaquine Combined Regimen in Adult Cohort of Plasmodium vivax Malaria from Primary Care Centres in Southwestern India.
Saravu K; Kumar R; Ashok H; Kundapura P; Kamath V; Kamath A; Mukhopadhyay C
PLoS One; 2016; 11(6):e0157666. PubMed ID: 27315280
[TBL] [Abstract][Full Text] [Related]
13. Interactions among primaquine, malaria infection and other antimalarials in Thai subjects.
Edwards G; McGrath CS; Ward SA; Supanaranond W; Pukrittayakamee S; Davis TM; White NJ
Br J Clin Pharmacol; 1993 Feb; 35(2):193-8. PubMed ID: 8443039
[TBL] [Abstract][Full Text] [Related]
14. A pilot randomized controlled trial to compare the effectiveness of two 14-day primaquine regimens for the radical cure of vivax malaria in South India.
Saravu K; Tellapragada C; Kulavalli S; Xavier W; Umakanth S; Brahmarouphu G; Srinivas NK; Channabasavaiah JP; Bava A; Saadi AV; Guddattu V; Satyamoorthy K; Bhat K
Malar J; 2018 Sep; 17(1):321. PubMed ID: 30176897
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of primaquine in man. II. Comparison of acute vs chronic dosage in Thai subjects.
Ward SA; Mihaly GW; Edwards G; Looareesuwan S; Phillips RE; Chanthavanich P; Warrell DA; Orme ML; Breckenridge AM
Br J Clin Pharmacol; 1985 Jun; 19(6):751-5. PubMed ID: 4027118
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic assessment of chloroquine-primaquine combined regimen in adult cohort of Plasmodium vivax malaria from a tertiary care hospital in southwestern India.
Rishikesh K; Kamath A; Hande MH; Vidyasagar S; Acharya RV; Acharya V; Belle J; Shastry AB; Saravu K
Malar J; 2015 Aug; 14():310. PubMed ID: 26259839
[TBL] [Abstract][Full Text] [Related]
17. Lack of sex effect on the pharmacokinetics of primaquine.
Elmes NJ; Bennett SM; Abdalla H; Carthew TL; Edstein MD
Am J Trop Med Hyg; 2006 Jun; 74(6):951-2. PubMed ID: 16760502
[TBL] [Abstract][Full Text] [Related]
18. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
St Jean PL; Xue Z; Carter N; Koh GC; Duparc S; Taylor M; Beaumont C; Llanos-Cuentas A; Rueangweerayut R; Krudsood S; Green JA; Rubio JP
Malar J; 2016 Feb; 15():97. PubMed ID: 26888075
[TBL] [Abstract][Full Text] [Related]
19. Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania: a randomized, single-blinded clinical trial.
Mwaiswelo R; Ngasala B; Jovel I; Aydin-Schmidt B; Gosling R; Premji Z; Mmbando B; Björkman A; Mårtensson A
Malar J; 2016 Aug; 15(1):435. PubMed ID: 27565897
[TBL] [Abstract][Full Text] [Related]
20. Promising approach to reducing Malaria transmission by ivermectin: Sporontocidal effect against Plasmodium vivax in the South American vectors Anopheles aquasalis and Anopheles darlingi.
Pinilla YT; C P Lopes S; S Sampaio V; Andrade FS; Melo GC; Orfanó AS; Secundino NFC; Guerra MGVB; Lacerda MVG; Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Stoops CA; Baldeviano GC; Tarning J; Vasquez GM; Pimenta PFP; Monteiro WM
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006221. PubMed ID: 29444080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
